CASSIE HARRISON: Open Payments
NPI 1710629852 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 11 payments from 8 companies in 2025. Trend: 2023 $559 · 2024 $555 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $267 |
| Otsuka America Pharmaceutical, Inc. | 2 | $240 |
| AstraZeneca Pharmaceuticals LP | 2 | $208 |
| Edwards Lifesciences Corporation | 1 | $139 |
| ABBVIE INC. | 1 | $131 |
| Apellis Pharmaceuticals, Inc. | 1 | $120 |
| Solventum Corporation | 1 | $100 |
| Ceribell, Inc. | 1 | $75 |
Products named: STRENSIQ, REXULTI, AIRSUPRA, SAPIEN 3 Ultra RESILIA, QULIPTA, Empaveli, V.A.C. VERAFLO, POCKET EEG DEVICE.
Industry payments across FL — which companies pay providers there.
